CLASSICAL PATHWAY LECTIN PATHWAY ALTERNATIVE PATHWAY Antigen:antbody complex Lectin binding to pathogen Pathogen surfaces surfaces Complement activation Recruitment of Opsonization Kiling inflammatory cells of pathogens of pahogens 1997 Current Bioloay Ltd.Garland Publishing.Inc
Complement proteins opsonize microbes and promote their phagocytosis. Encapsulated bacteria resist Binding of antibody to becterial Uptake of bacteria into Granules fuse with phagosomes uptake by neutrophils and surface also leads to the binding neutrophil phagosomes mediated producing toxic oxygen avoid engulfment of the complement protein,C3b by Fc and C3b receptors metaboltes that kill bactera 1997 Current Biology Ltd./Garland Publishing.Inc
Complement proteins opsonize microbes and promote their phagocytosis
Complement receptors on the surface of leukocytes bind complement proteins Phagocytic receptors:CR1,CR3,CR4 present on neutrophils,monocytes, macrophages,dendritic cells. Bind C3b C3bi that are attached to microbial surfaces (as opsonins)-> phagocytosis
Complement receptors on the surface of leukocytes bind complement proteins Phagocytic receptors: CR1, CR3, CR4 - present on neutrophils, monocytes, macrophages, dendritic cells. - Bind C3b / C3bi that are attached to microbial surfaces (as opsonins) → phagocytosis
Complement receptors on the surface of leukocytes bind complement proteins CR2:surface of B cells and dendritic cells. Binding of activated complement fragments to CR2 amplifies antigen-induced cellular activation provides a link between the innate and acquired immune systems
Complement receptors on the surface of leukocytes bind complement proteins CR2: surface of B cells and dendritic cells. Binding of activated complement fragments to CR2 amplifies antigen-induced cellular activation - provides a link between the innate and acquired immune systems
CLASSICAL PATHWAY LECTIN PATHWAY ALTERNATIVE PATHWAY Antigen:antbody complex Lectin binding to pathogen surfaces Pathogen surfaces Complement acivation Recruitment of Opsonization Kiling inflammatory cells of pathogens of pathogens 1997 Current Bioloay Ltd./Garland Publishing.Inc